Blog articles
Where does linearity end - is there an "upper limit"?

Introduction
Although this time it’s not about pharmaceutical method validation1, I’d like to take up an interesting question about the upper limit of linearity. We’ve got the following topic: For the performance of real-time polymerase chain reactions (RT-PCR) to detect SARS-CoV-2, the comparability of 2 thermal cyclers should be determined. For this purpose, the Ct values of the two thermal cyclers (let's call them A and B) were plotted against each other at different sample concentrations.
Review of the book "Endotoxins and pyrogens"

As usual, I was once again accompanied on my last vacation by a technical book, which I’d now like to present. In this case, it is "Endotoxins and Pyrogens - Detection Methods, Product Testing, Inactivation", which was published by Michael Rieth at Wiley-VCH GmbH, Weinheim in 2021 as first edition (ISBN: 978-3-527-34695-0).
Testing for sterility: background, performance and verification (method suitability test)

In today's blog article, we’d like to take a look at sterility testing and its verification. As this is a compendial method, we should talk about verification instead of validation in this context, even though unfortunately we often still read about validation of this method. To stick with the wording, in the pharmacopoeias this is referred to as method suitability test (MST), which in my opinion fits very well 😉
- Review of the book "Laborstatistik für technische Assistenten und Studierende " (Laboratory statistics for technical assistants and students)
- New potency assays for anti-VEGF antibodies
- Lots of sensitivities, or: How do analytical, diagnostical, and functional sensitivity differ?
- LOD: What’s behind the "3.3" or: the underlying statistics